This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The investigations of fibrosing alveolitis should include:

  • chest radiology
  • blood tests:
    • ESR usually raised
    • anti-nuclear factor positive in about 45%
    • rheumatoid factor in about 35% of patients - there is an association with rheumatoid arthritis
    • increased gamma-globulin
  • CT is sensitive for the diagnosis and monitoring of pulmonary fibrosis
  • bronchoscopy and bronchoalveolar lavage:
    • neutrophils and/or eosinophils are increased
    • lymphocytes may also be raised (may be suggestive of favourable treatment response)
  • pulmonary function tests:
    • restrictive defect
    • lung volumes reduced
    • lung compliance reduced
    • blood gases are normal until advanced disease when there may be arterial hypoxaemia and hypocapnia
    • transfer factor is characteristically reduced

Transbronchial or open lung biopsy allows histological analysis. This is not often indicated because of the sensitivity of diagnosis via CT scan.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.